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The purpose of this study was to evaluate the effect of a
home physiotherapy program for persons with Parkinson’s
disease. Thirty-three patients took part in the study using a
within-subject controlled design. Functional activities in-
cluding walking and carrying out transfers were measured
at home and in the hospital before and after a 6-week
baseline period, after 6 weeks home physiotherapy and after
3 months follow-up. Spatiotemporal and plantar force
variables of gait were determined with video and podody-
nography. Treatment provided by community physiothera-
pists consisted of teaching cueing and conscious movement
control 3 times a week. The study revealed that patients had
signi cantly higher scores on a functional activity scale after
treatment in the home setting and to a lesser degree in
hospital, a result, which was partly sustained at follow-up.
However, duration of the transfer movements, spatiotem-
poral and plantar force variables were not signi cantly
improved except for stride length. The results support
application and development of the treatment concept and
highlight that physiotherapy aimed at improving function in
Parkinson’s disease is best provided in the home situation.
Key words: Parkinson’s disease, rehabilitation,
physiotherapy, gait, effect.
J Rehabil Med 2001; 33: 266–272
Correspondence address: Alice Nieuwboer, Department of
Rehabilitation Sciences, Faculty of Physical Education and
Physiotherapy, Katholieke Universiteit Leuven,
Tervuursevest 101, BE-3001 Leuven, Belgium. E-mail:
alice.nieuwboer@ ok.kuleuven.ac.be
(Accepted April 12, 2001)
INTRODUCTION
The effectiveness of physiotherapy in alleviating functional
activities of people with Parkinson’s disease (PD) has been
subject to limited scienti c scrutiny. This may be due to the fact
that the intrinsic value of physiotherapy has been under-
estimated in comparison with the bene ts of medication.
Moreover,we found that the side effects of drug use complicated
scienti c evaluation (1).
A number of studies showed a signi cant short-term effect on
function after programs of general exercise administered in
either the home situation (2), as group training (3–5) or as
individual hospital-basedtreatment (6). However, contemporary
authors (7, 8) put greater emphasis on specifying the concepts
behind rehabilitation in PD outlining two possible paradigms.
The  rst is aimed at overcoming the physical limitations
secondary to inactivity and disuse. In this context recent
research has highlighted the potential for improving cardio-
respiratory  tness (9, 10), trunk muscle strength (11) and spinal
mobility (12) through speci c training in mild to moderately
affected patients. The second approach intends to tailor
rehabilitation to insights into the speci c nature of basal ganglia
de cits (7, 13, 14). It is generally accepted that basal ganglia
pathways control the automatic execution of movement gener-
ated in cortical motor areas (15). The core de cit underlying
brady- and akinesia is the inability to drive motor output
internally in well-learned sequential and complex tasks (16).
Hence, physiotherapy methods may be able to compensate for
the loss of the internal motor generator through the allocation of
attention and external reference points (7, 13, 14). Numerous
studies on the effect of verbal, visual and auditory cues
established short term bene ts on the quality of gait (17–20)
and on overcoming initiation dif culties and freezing (21, 22).
Some preliminary work indicated that implementing cues,
cognitive planning and breaking down complex tasks into their
component parts enhanced functional motor performance in
individuals with considerable disease duration (13, 14).
While these studies indicate the potential for more optimal
motor output, the most burning question for clinical practice is
whether these strategies will transfer to conditions where
sensory cues and attention are not available or otherwise
engaged. The relevance of this issue came out of a series of
experiments on training locomotion with visual cues and
attention (18). Improvement of gait speed acquired through
practice yielded no carry-over on performance the following
day. Likewise, offering secondary cognitive tasks showed
interference with the improved quality of gait. Both the
continued dependence on external control and the so-called
‘in exibility of motor behaviour’ often associated with PD (15)
underscore the importance of rehabilitation of everyday actions
in the very environment in which they usually take place.
Taking these  ndings together illustrate the need for further
explorationof the value and feasibility of treatmentmodalities in
line with the second rehabilitationparadigm.The present study is
Ó 2001 Taylor & Francis. ISSN 1650–1977 J Rehabil Med 33
J Rehabil Med 2001; 33: 266–272
meeting this need, as its primary objective is to investigate the




We used a within-subject controlled design accounting for the problems
of heterogeneity and within-patient variability inherent in this population
(1). After admission into the trial patients entered a baseline period of 6
weeks in which they did not receive physiotherapy (Fig. 1). Concurrent
measurements of the main outcome variables took place in the home and
the hospital within the same week, at onset and at completion of the 6-
week baseline period (testB1 and testB2). Parallel measurements in both
settingswere repeated after a 6-week rehabilitation program (testT) and a
follow-up period of 3 months (testF). Total duration of the study period
was 6 months.
Intervention
Physiotherapy treatment aimed to reduce the speci c dif culties
experienced during functional activities rather than improving move-
ment speed. Therefore, treatment was provided in the home setting.
Treatment principles consisted of cueing, conscious control, biomech-
anical compensation and repetition in different circumstances to enhance
the quality of gait, chair rising, bed mobility and the occurrence of gait
blocks. For training bed mobility strategies described by Kamsma et al.
(13) were adopted, involving structured sequences of movements
adapted to each individual’s needs. Treatment for rising from the chair
entailed strategies to reposition the center of mass in relation to the base
of support to compensate for slow trunk  exion and insuf cient
horizontal momentum (23). Gait aspects were trained using visual and
auditory cues and self-instruction to improve step length, foot roll-off,
posture, initiation, turning and freezing (7, 13, 18, 20, 21). Therapists
decided for themselves which cue or instruction was most bene cial and
would be included in the program. A therapist of choice provided 3
treatment sessions of 30 minutes a week for 6 weeks. Thirty-two
physiotherapistsparticipated in the studywith an average age of 39 years
(range 24–58 years) and a mean professional experience of 16.2 years
(range 2–26 years). To ensure a standardized treatment approach:
1. Therapists received an instruction booklet and video outlining the
rationale and execution of treatment.
2. The researcher checked adherence to the trial guidelines and
treatment principles during a visit and aided in setting the speci c
goals for each patient.
3. Therapists had to record the frequency, duration and treatment
strategies used, enabling post-trial exclusion if treatment did not
meet the requirements of the study.
Subjects
Patients regularly attending a university hospital outpatient clinic for
movement disorders volunteered to partake in the study. They were
resident in the community within a radius of 1.5 hours’ driving distance
from hospital and selected from a cohort of 275 persons with PD over a
period of 18 months.We recruited patients with a diagnosis of idiopathic
PD according to accepted research criteria (24), with a stable medication
regimen, with hindrance of functional disability, without current
engagement in physiotherapy, without dementia (>23, Mini-Mental
State Examination (MMSE) (25)), without acute other medical problems
and with signi cant periods of the day free of severe dyskinesias and
unpredictable off-periods.
Procedures
At entry into the study we classi ed patients into Hoehn & Yahr grades
(26) in both “on” and “off” phases. The MMSE (25) documented the
level of cognitive functioning. As a measure of disease severity we
employed the Uni ed Parkinson’s Disease Rating Scale (UPDRS) (27) at
onset (testB1), after treatment (testT) and after follow up (testF). Patients
also completed the Dutch version of the 30-item Geriatric Depression
Scale (28) (GDS-30) before and after therapy.
To control for the confounding effects of medication, subjects had to
adhere strictly to their usual medication schedule. We reminded patients
by telephone to comply with this measure before the day of testing. At
each test we veri ed whether the regimen still applied and had been
complied with. Also, we recorded the time of medication intake and
standardized the timing of tests accordingly. Tests took place during the
“on”-period, between 1 and 2.5 hours after taking the last L-dopa dose.
Three times during each test patients rated themselves as having been in
the “on”, “wearing off” or “off” phase during the previously performed
part of the test. These “on”–“off” ratings enabled post-hoc inclusion of
data obtained during “on” only.We de ned the “on” phase as the typical
“peak dose” level ofmotor performance when the action of medication is
considered optimal. We de ned the “off” phase as the typical “end of
dose” level of motor performance when the action of medication is
strongly decreased or absent. “Wearing off” was considered as the
unstable period in which patients are changing from “on” to “off”.
Outcome measures
As the primary outcome measure we used an activity scale in both
settings, which we had tested earlier for internal consistency, inter-rater
and test–retest reliability (1). This 10-item instrument (range of scores 0–
40) involved scoring the effectiveness of functional activities on a scale
from zero to four in the following areas:
1. Initiating gait and turning, scoring the occurrence of hesitation,
festination and freezing (2 items on gait akinesia).
2. Rising from and sitting down into a chair, scoring dif culties with
controlling the center of bodymass and the need for arm support (2
items on chair transfers).
3. Rolling and transferring in and out of bed, scoring dif culties with
Fig. 1. Overview of study procedure and dropout.
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axial mobility and achieving an adequate position in bed (3 items
on bed mobility).
4. Handling the bed covers as well as moving in and out of bed,
scoring dif culties with performing complex movement and
double tasks (3 items on bed mobility with cover).
The same tester administered the activity scale in both the hospital and
the home using standard instructions and test circumstances. In the
hospital we recorded performance on the items of the activity scale on
video. After completion of the trial, we randomized the order of the tests
yielding a blind scoring procedure.
Additionally, the tester measured stride length and speed of sit to
stand, supine to sit and gait using two-dimensional videotaping in the
hospital. Video camera placement (two cameras) was standardized and
optimized to avoid parallax error and increase measurement resolution.
The cameras stood perpendicular to the plane of motion and were
calibrated using a frame of reference behind the measurement target. For
gait analysis patients walked on a 6-meter walkway at their normal
comfortable speed. We calculated gait velocity and stride length from
the markers attached to the shoes of the patient using custom-made
software. Two independent testers established the inter-tester reliability
of the procedure (ICC = 0.99). However, the same tester carried out the
data processing for the purpose of this study. We also recorded the
duration of a controlled protocol of chair and bed rises. Subjects stood up
from a chair without armrests upon a verbal signal keeping the arms
folded across the chest. The tester adjusted the seat height in relation to
the length of the shank and the placement of the feet obtaining an angle
of approximately 80° between lower legs and horizontal. In a similar
fashion patients were asked to get up from supine lying to sitting from a
bed of 40 cm height using their preferred method. The settings were
standardized for subsequent measurements. During gait analysis we also
recorded temporal data of the two most central strides of the walking
trajectory and the plantar force distribution of the foot with a portable
pododynography system (29). Patients wore standardized shoes avail-
able in different sizes with pressure sensitive insoles as part of the
system. Each sole contained 64 pressure sensors. Sampling frequency
was 50 Hz lasting 10 seconds. A detailed description of the measurement
materials and calculation methods was given in a previous publication
(29). For this study, we calculated the impulses or the plantar force/time
products for the heel, mid-foot, forefoot and toes regions. We averaged 2
successful trials of the timed sit to stand and supine to sit movements and
of 2 consecutive gait cycles for statistical analysis.
Data analysis
We calculated UPDRS scores by averaging scores from multiple body
parts, in case of asymmetry of the most affected side. Results of the
activity scale were summed into a total score and 4 sub-scores (gait
akinesia, chair transfers, bed mobility and bed mobility with cover) as
proposed in a previous investigation (1). The distribution of activity
scale scores justi ed a parametric approach to data analysis. Missing
values occurred as a result of technical failure, dropout at follow-up and
random occurrence of “wearing off” or “off” phases. Considering the
repeated measures design and the problem of missing values we used a
linear mixed statistical model. The calculation of regression lines for
each individual as well as for the entire group, inherent to this technique,
corrected for missing values (30). We  tted the models using maximum
likelihood estimations with the SAS PROCMIXED (31). Because of the
exploratory nature of the studywe did not correct for multiple testing. To
investigate the occurrence of dropout at follow-upwe performed logistic
regression analysis. Age was included as a confounding variable in the
regression models and interaction effects with age were checked but
found insigni cant (p> 0.05). To test if patients’ mood changed after
treatment we employed McNemar and Wilcoxon signed rank tests. We
considered patients as either not depressed (GDS-30 score between 0 and
10) or depressed (11–20mild depression, 21–30 severe depression) (28).
RESULTS
Subjects
Thirty-nine patients entered into the study. During the  rst 12
weeks 6 patients dropped out or were excluded from the trial
(Fig. 1). One patient died due to heart failure. Two developed
additional neurological symptoms possibly indicating non-
idiopathic PD. Two subjects required adjustments of medication
and one patients’ rehabilitation program did not ful ll the
intensity criteria of the study.We were left with 33 patients,who
completed the baseline and treatment periods. At 6 months
follow-up 7 patients dropped out from the tests because 2
patients became ill from other medical conditions than PD, 1
was unwilling to cooperate and 4 required alterations of their
medication regimen. A further 8 patients dropped out for the
hospital follow-up, as one patient developed acute thrombosis
between the home and hospital tests and 7 were unwilling to
cooperate because of the traveling involved, leaving a total of 18
participants.
The 33 patients who completed the  rst 3 months of the trial
were 21 males and 12 females mainly of Hoehn & Yahr grade
II.5 (n = 15) and III (n = 16) during the “on” phase as
demonstrated in Table I. In the “off” phase 21 persons were in
grade IV. Mean Mini Mental Scale score was 26.9 (range 23–
30). Table I summarizes the daily medication regimens patients
were taking during the study period. The most frequently
concurring medical problems affecting mobility were chronic
back pain (n = 6) and peripheral arthroses (n = 6). Three patients
had had previous hip fractures. Five patients reported cardio-
vascular problems and 3 chronic pulmonary disease in addition
to PD.
Sixteen patients suffered from recurring “on”–“off”  uctua-
tions during the day as measured by the UPDRS. During actual
testing 7 patients in the hospital and 4 in the home experienced a
random change of their “on” phase. Sixteen subjects reported to
have choreiform movements for some time during the day. The
level of dyskinesiasexperiencedduring test sessionswas mild to
moderate in 5 patients and marked in 3 cases. No dystonia was
observed.
Effect of treatment on the activity scale scores
Table II shows the results of the linear mixed model on the
functional activity scale in the home and hospital setting
estimating the size and signi cance of the effects of the baseline,
treatment and follow-up periods. A mild improvement of
activity scale scores was apparent during the baseline period at
home, signi cant for gait akinesia (p = 0.04), bed mobility with
manipulating the cover (p = 0.03) and total function (p = 0.02).
None of the baseline increments were signi cant in the hospital
setting. After the treatment period, activity scale scores
improved signi cantly in all areas at home (0.0001< p<
0.004). The size of these effects was estimated to vary from
0.65 to 1.95 points on the scale for the different functional
activities. Total activity scale scores at home increased with 5.2
points implying an increment of 21.5% of the mean initial score.
In the hospital signi cant improvements were found for gait
akinesia, chair transfers and total activity scale scores after
treatment (0.0001< p< 0.007). Changes of bed mobility with
and without cover were either borderline or not signi cant
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(p = 0.05 and p = 0.29). Overall effect size was smaller in the
hospital. Total activity scale scores enhanced with 2.28 (8.6%)
points on the scale.
Because a consistent “baseline effect” was detected, albeit not
signi cant in most cases, the impact of therapy was further
explored assuming that this effect would recur during the
treatment period. After subtraction of baseline increments the
scores remained signi cant for chair transfers (p = 0.04), bed
mobility without and with cover (p = 0.03 and 0.002) and the
total activity scale (p = 0.0008) after treatment at home. In the
hospital chair transfers continued to display a signi cant effect
(p = 0.002).
Looking at the effect of treatment after three months follow-
up revealed that the estimated change of activity scale scores
was smaller compared with that of immediately after treatment.
However, both at home (p< 0.0007, 12.6%) and in the hospital
(p = 0.03, 5%) total activity scale scores still showed a
signi cant difference compared with the second baseline
measurement.
Whereas Table II displays the effects predicted by the
statistical model, Fig. 2 depicts the actually observed mean
total scores at the four tests in both environments. From this
 gure it is apparent that at baseline patients performed overall
better in the hospital than in the home situation, differences,
which did not reach statistical signi cance (p = 0.09). A
continued improvement is shown between testT and testF in
the hospital,which was not predicted by the linear mixed model.
To explore this discrepancy the considerable dropout of
particularly the hospital evaluations was further investigated.
Logistic regression exposed that patients with lower total
activity scale scores at baseline and after treatment in the
home situation had a signi cantly greater chance to drop out at
follow-upwith p-values ranging from 0.02 to 0.03 and intercepts
from 3.2 to 4.1. From the hospital scores predictionswere almost
signi cant (p = 0.08 and 0.09, intercept = 3.5 and 3.8). This
outcome justi es the use of the linear mixed approach in
correcting for in ation of the results due to dropout of the worst
cases.
Effect of treatment on additional variables
Table III summarizes the effects on spatiotemporal gait par-
ameters as predicted by the statisticalmodel. At the  rst baseline
evaluation patients walked with a mean velocity of 0.87 meter/
second (§0.23), mean stride of 0.99 meter (§0.23), mean
cadence of 103.8 steps/minute (§12) and mean double support
phases of 26.6% (§ 6.2). Baseline instability was not mean-
ingful. A signi cant treatment effect (p = 0.004) was recorded
for stride length whichwas estimated to increasewith 0.09meter
after therapy (9%). The net effect of this improvement on speed
was counteracted by an almost signi cant reduction of cadence
with 3.7 steps per minute (p = 0.08) resulting in a moderate
velocity increase of 0.035 meter/second. Double support
Table I. Clinical characteristics of the patients (n = 33)
n Mean (range)






Age (years) 66.2 (49–81)




Daily dose of medication (mg)
Levodopa 33 640.7 (200–1000)
Bromocriptine 6 22.5 (15–30)
Pergolide-mesylate 12 2.3 (0.75–3)
Amantadine-HCl 17 161.8 (100–200)
Selegeline-HCl 11 7.7 (5–10)
Table II. Estimate effects (b), the standard errors (s.e.) and the signi cance (p) of the activity scale scores in the home and the hospital. The
number of subjects (n) varied due to dropout and to random occurrence of “off” or “wearing “off” as rated by the patients themselves







b (SE) p b (SE) p b (SE) p
Home (range) n = 31–33 n = 31–32 n = 25–26
Gait akinesia (0–8) 0.45 (0.21) 0.04 0.65 (0.21) 0.004 0.16 (0.24) 0.52
Chair transfer (0–8) 0.05 (0.23) 0.84 0.99 (0.29) 0.002 0.45 (0.27) 0.11
Bed mobility (0–12) 0.44 (0.29) 0.15 1.57 (0.34) 0.0001 1.27 (0.32) 0.0005
Bed mobility ‡cover (0–12) 0.61 (0.27) 0.03 1.95 (0.26) 0.0001 1.32 (0.44) 0.006
Total score (0–40) 1.61 (0.64) 0.02 5.16 (0.60) 0.0001 3.04 (0.79) 0.0007
Hospital (range) n = 26–31 n = 26–32 n = 15–17
Gait akinesia (0–8) 0.01 (0.03) 0.66 0.08 (0.03) 0.007 0.06 (0.03) 0.06
Chair transfer (0–8) 0.14 (0.19) 0.46 1.26 (0.21) 0.0001 0.48 (0.27) 0.09
Bed mobility (0–12) 0.21 (0.34) 0.55 0.54 (0.26) 0.05 0.63 (0.34) 0.08
Bed mobility ‡cover (0–12) 0.30 (0.28) 0.29 0.39 (0.36) 0.29 0.44 (0.36) 0.23
Total score (0–40) 0.75 (0.48) 0.13 2.28 (0.61) 0.001 1.53 (0.65) 0.03
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duration decreased after treatment but not signi cantly. Effects
on roll-off of the foot as re ected by the plantar force
distribution patterns are not represented in Table III rendering
insignicant results. At follow-up the improvement of stride
length disappeared and was no longer meaningful when
compared with baseline levels (testT – testB2). Unlike the
predicted decrease of stride length at follow-up, an actual mean
increase of 0.025 meter was measured, resembling the dis-
crepancy between estimated and actual results for total function
in the hospital discussed earlier. Results of logistic regression
analysis con rmed that patients with a better gait pro le were
more likely to remain in the study at follow-up. Shorter stride
lengths after the baseline (intercept = 4.5, p = 0.04) and treat-
ment periods (intercept = 8.2, p = 0.03) signi cantly predicted
dropout. Patients’ mean duration of rising from a chair being
2.46 second (§0.68) at onset of the study did not signi cantly
alter throughout the study period nor did the duration of moving
from supine to sit (X– = 10.5§ 5.1 second).
Non-specic effects
Before treatment 19 patients were considered not depressed and
14 mildly depressed as indicated by the Geriatric Depression
Scale (28) (GDS-30). After treatment 4 previously (mildly)
depressed patients became not depressed and in one patient the
opposite change occurred, a result, which was not signi cant
(p = 0.18). Alterations of the mean GDS-30 score were also not
meaningful (p = 0.12).
Patients presented with a mean UPDRS total score (“on”
phase) of 50.5 (§10.8) at baseline. We found a signi cant
(p = 0.02) mean improvement of 2.4 points of UPDRS scores
after treatment, 4.8% of the initial score, which returned to
baseline levels at follow-up. Effects on the subscales of the
UPDRS were only signi cant for the ADL-section (part II)
which got better immediately after treatment (p = 0.03, b = ¡1)
but deteriorated at follow-up.
DISCUSSION
Rehabilitation professionals need to know whether providing
speci c physiotherapy to functionally impaired individualswith
PD is worthwhile. From earlier studies the appropriateness of
teaching conscious control to replace the disrupted automatic
motor planning emerged (13, 14, 18). The current study supports
the use of this rehabilitation concept as implementing such
treatment at home led to more effective performance of
functional activities in patients with a mean disease duration
of 12 years. Clinically relevant improvement was demonstrated
on a speci c activity scale (8.6–21.5%) which was con rmed by
the UPDRS (4.8%). The impact is modest comparedwith that of
medication, established in similar populations to be 37% on
function, 35% on gait velocity and 30% on stride length (32).
However, in view of the presence of signi cant functional
disability, possible improvement from physiotherapy may be a
meaningful addition to pharmacological treatment.
We propose that one of the mechanisms underlying the
improvement may stem from the conscious activation of motor
cortex overriding the loss of basal ganglia function. Recent
research suggested that over-activity in the unaffectedcerebellar
and lateral premotor routes may signify an adaptive mechanism
through which patients can use sensory or attentional guidance
to overcome their movement disorders (33). A second mechan-
ism may be that repeating the functional movements in
themselves is bene cial, especially when under the in uence
Fig. 2. Means and standard errors of the total activity scale scores
in the hospital and home setting at baseline (testB1 and testB2) after
treatment (testT) and after follow-up (testF).
Table III. Estimate effects (b), standard errors (s.e.) and the signi cance (p) of the spatiotemporal gait variables. The number of subjects (n)
varied due to dropout and to random occurrence of “off” or “wearing off” as rated by the patients themselves during performance of







b (SE) p b (SE) p b (SE) p
Hospital n = 26 n = 26–32 n = 14
Velocity (meter/second) 0.027 (0.02) 0.13 0.035 (0.02) 0.12 0.01 (0.03) 0.61
Stride length (meter) 0.03 (0.02) 0.11 0.09 (0.004) 0.004 0.03 (0.03) 0.29
Cadence (steps/minute) 0.11 (1.76) 0.95 ¡3.7 (2.0) 0.08 ¡1.18 (1.91) 0.25
Double support phase (%) 1.7 (0.9) 0.06 ¡1.5 (1.0) 0.16 ¡0.2 (0.74) 0.79
n = 39 informed consent.
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of cues the execution of functional activities occurs in the most
optimal way.
An interesting and novel  nding was that the effect was most
convincing in the very context in which training took place.
Improvement of functional activity scores at home were more
than twice those observed in hospital. In our view, this
discrepancymay be explained by a better retention of treatment
strategies within the actual learning-context.Motor learning in
healthy subjects is generally regarded as highly task-specic but
evidence on context-specicity is more limited (34). Over and
above these general learning issues, the intrinsic features of
basal ganglia de cits and associated cognitive change may
clarify the moderate transfer to a different environment. PD-
patients’ inability to internally drive motor output results in a
striking sensitivity to the external and mental conditions under
which motor behavior is performed. Inasmuch as this factor is
used to its advantage in therapy it may also assume limitations
where generalization is concerned. The cognitive dysfunction in
non-demented patients with PD in terms of shifting appropriate
attention to new demands and activatingmemory processesmay
exacerbate these dif culties (35). We therefore interpret the
context-specic results as an integral part of the disease which
may prove hard to redress as patients have lost the ability to
internally self-generate their maximal motor output. For clinical
practice this underscores the relevance of providing rehabilita-
tion in the home situation as well as practicing a variety of tasks
in different conditions and circumstances.
The weaker results found in hospital may also be due to the
methodological limitations of this study. The use of video-
technology permitted retrospective randomization of tapes and
blind scoring in hospital. Both for practical reasons and to create
a familiar test atmosphere no equipment was used at home
where awareness of the test order may have created observer
bias.
The improvements found essentially indicate that patients had
less speci c dif culties in accomplishing the activities trained,
i.e. turning with less hesitation and freezing, rising from a chair
without falling back and achieving a comfortable position in
bed. Increments of the UPDRS ADL-section rather than of the
motor examination part con rm that the bene ts of therapy
occur at activity rather than at impairment level of the ICIDH
hierarchy (36). No meaningful change occurred of the duration
of test movements demonstrating an acceleration of perfor-
mance and accentuating the contents-specicity of the effects.
The isolated improvement of stride length without carry-over to
gait speed and roll-off of the foot provides further evidence of
speci city. Training was focused on normalizing the typical gait
de cits of reduced stride length and roll-off of the foot rather
than on producing a faster gait as such. Moreover, during
evaluation patients were asked to walk with normal speed and
were not reminded of the contents of therapy. The trend towards
a reduced mean cadence supports the view that patients utilize
stepping rate as an adaptivemechanism for the fundamental loss
of stride length (18). Although speed did not improve, it can be
argued that patients’ gait normalized in terms of the stride/
cadence relationship. However, normalization did not re ect
itself in an alteration of plantar force distribution. This is in
agreement with other studies (37, 38) in which correction of
kinematic and spatiotemporal variables coincided with persis-
tent abnormalities of the kinetics of gait in response to visual
cues. The fact that force production at the foot remained
abnormal despite intervention raises questions as to the exact
working mechanism of cues and self-instruction.More research
into this area is called for clarifying how this mechanismmay be
exploited to greater bene t. In agreement with  ndings on
general exercise (4, 6) the effects of intervention subsided 3
months after therapy but performance of the trained activities in
both settings continued to be signi cantly better with the
exception of stride length. This result was obtained while
statistically correcting for dropout. A need for adjustment of
medication and a waning commitment to the trial were the most
frequent reasons for dropout. Patients with poorer motor
performance ran a higher risk of dropping out. The illustrated
vulnerability of the population in relation to the demands of the
study imposes limitations on future study design. The size of the
effects, the heterogeneity of PD in general and the drug side
effects inherent to prolonged disease argue against the use of a
control group in studies constrained by limited numbers of
available patients. The present design provided a within-subject
controlled design. Baseline results were not always stable.
Several explanations must be explored in this context. A
learning effect is conceivable but unlikely considering that
when six repeated tests of the same functional activities were
carried out in one day no such effects were evident (1). Baseline
improvement might have been caused by patients’ raised
expectations and enhanced psychological well being, factors
that were suggested to constitute part of the effect of rehabilita-
tion in PD in other studies (10, 13). However, no evidence of
positive mood changes was found. Future studies should allow
more frequent repeated measures to enable accurate prediction
of the slope of baseline effects taking into account the possibility
of dropout of the most vulnerable patients.
The patients included in this study were without severe
 uctuations and cognitive decline. They displayed a willingness
to go through multiple measurements sometimes requiring
considerable travel. The implied cooperation of the population
projects onto the generalizationof the results. On the other hand
rehabilitation was provided by a sample of average rather than
specialized community therapists, a notion, which stresses the
pertinence of the outcome.
This within-patient controlled trial provides some new
insights into the applicability and value of physiotherapy
addressing activities, instrumental to preserving independence
in advanced PD. Stimulating reliance on contextual stimuli and
conscious control seem effective as a compensatorymechanism
to improve function, an effect, which is partly sustained at 3
months follow-up. However, the limitations imposed by basal
ganglia dysfunctionon the capacity for permanent learning also
emerge as limited transfer occurs to a different context. The
speci city of the effects in terms of context and contents has to
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be taken on board by the rehabilitation profession and by those
who refer patients to the service. Therapists have to advance the
paradigm identifying methods to promote generalization and to
address the speci c effects of cues.
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